Zobrazeno 1 - 10
of 375
pro vyhledávání: '"Tzanatos H"'
Autor:
Tzanatos, H.1,2 (AUTHOR), Dalamangas, A.1 (AUTHOR), Retsa, K.1 (AUTHOR), Kapetanaki, A.1 (AUTHOR), Agroyannis, B.1 (AUTHOR)
Publikováno v:
Renal Failure. Mar2005, Vol. 27 Issue 2, p235-238. 4p.
Publikováno v:
Clinical Nephrology. 73:449-453
UNLABELLED Under certain circumstances when patients need peritoneal dialysis (PD) but no physical unit or official staff are available, one has to improvise ways to serve such patients. In this study we describe our experience with such patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f505bb2e4fc3bac431576e9b3c37df93
https://doi.org/10.5414/cnp73449
https://doi.org/10.5414/cnp73449
Hepcidin has emerged as a peptide with a key role in the regulation of iron homeostasis in patients with chronic kidney disease (CKD), having a strong dependence on inflammation. Recent studies reveal that hepcidin may be also associated with the pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::75b24f8e5623d3b5dc48c1d1ffb1631a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127209
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127209
Postoperative liver failure remains a major cause of morbidity and mortality after extensive hepatectomies. This study aims to evaluate the effectiveness of a hepatocyte bioreactor in the treatment of experimental post-hepatectomy liver failure. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::4a876b50bd03a008e98cc8c46bedcbba
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2981687
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2981687
Autor:
Agroyannis, B., Kopelias, I., Fourtounas, C., Paraskevopoulos, A., Tzanatos, H., Dalamangas, A., Mallas, E.
Publikováno v:
Artificial Organs; Jun2001, Vol. 25 Issue 6, p486-490, 17p
Publikováno v:
Artificial Organs; Sep2000, Vol. 24 Issue 9, p743-745, 21p
The efficacy and safety of acipimox, an antilipolytic agent, were studied in 10 uremic patients under hemodialysis (group A) and in 8 renal transplant recipients with adequate renal function (group B). The medication was given for 20 weeks at a dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7c8d271c6700de61aaa80973c50e74db
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3135648
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3135648